GF:SIXGeorg Fischer AG Analysis
Data as of 2026-05-14 - not real-time
$11.82
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The New Germany Fund trades at a strikingly low trailing P/E of 3.45 versus an industry average of 16.45, suggesting a deep valuation discount. However, the balance sheet tells a cautionary story: a debt‑to‑equity ratio of 13.2 and negative operating margins raise concerns about financial stability. On the technical side, the stock sits above its 20‑day (11.76), 50‑day (11.18) and 200‑day (11.44) moving averages, with volume trending upward, while the RSI hovers around 55 and the MACD histogram is marginally negative, indicating a neutral to mildly bearish short‑term momentum. The fund pays a 2.4% dividend with a very modest payout ratio of 4.3%, which, despite zero operating cash flow, appears sustainable given the low distribution level.
Overall, the market sentiment is in an "Extreme Greed" phase (fear‑greed index 89.55), but the combination of high leverage, weak cash generation, and a modest upside ceiling suggests a cautious stance, especially beyond the immediate price action.
Overall, the market sentiment is in an "Extreme Greed" phase (fear‑greed index 89.55), but the combination of high leverage, weak cash generation, and a modest upside ceiling suggests a cautious stance, especially beyond the immediate price action.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above 20‑, 50‑ and 200‑day SMAs
- Increasing trading volume
- RSI in a neutral zone indicating room for upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant valuation discount versus peers
- High debt‑to‑equity and negative operating cash flow
- Low payout dividend supporting income but limited growth
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Sustainable dividend despite cash‑flow constraints
- Concentration in German mid‑cap equities exposing geographic risk
- Potential regulatory and leverage pressures limiting upside
Key Metrics & Analysis
Financial Health
Revenue Growth119.10%
Profit Margin1497.97%
P/E Ratio3.4
ROE31.04%
ROA0.37%
Debt/Equity13.19
P/B Ratio0.9
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI55.3
Support$11.16
Resistance$12.43
MA 20$11.76
MA 50$11.18
MA 200$11.44
MACDBearish
VolumeIncreasing
Fear & Greed Index89.55
Valuation
GradeUndervalued
TypeValue
Dividend Yield2.40%
Risk Assessment
Beta0.88
Volatility28.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.